Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China-Reference-Cited by-同舟云学术

Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China

Published:2015-09-14 Issue:11 Volume:93 Page:775-784
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:
Short-container-title:Bull. World Health Organ.

Author:

Fitzpatrick Christopher¹,Hui Zhang²,Lixia Wang²,Renzhong Li²,Yunzhou Ruan²,Mingting Chen²,Yanlin Zhao²,Jin Zhao²,Wei Su²,Caihong Xu²,Cheng Chen²,Alston Timothy¹,Yan Qu²,Chengfei Lv³,Yunting Fu²,Shitong Huan⁴,Qiang Sun³,Scano Fabio⁵,Chin Daniel P⁴,Floyd Katherine¹

Affiliation:

1. World Health Organization, Geneva, Switzerland.

2. National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control, Beijing, China.

3. Center for Health Management and Policy, Key Lab of Health Economic and Policy Research of Ministry of Health, Shandong University, No 44 Wenhua Rd, Mailbox 128, Jinan, Shandong 250012, China.

4. Bill & Melinda Gates Foundation, Beijing, China.

5. World Health Organization, Beijing, China.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference20 articles.

1. Global tuberculosis report 2011. Geneva: World Health Organization; 2011.

2. Global tuberculosis report 2013. Geneva: World Health Organization; 2013.

3. Agenda item 6.1. Global strategy and targets for tuberculosis prevention, care and control after 2015. In: 134th Session, Executive Board, 21 January 2014. Geneva: World Health Organization; 2014. Available from: http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_R4-en.pdf?ua=1 [cited 2015 Jun 16].

4. Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after study.;Li;Lancet Glob Health,2015

5. Cost-effectiveness and strategic planning (WHO-CHOICE) [Internet]. Geneva: World Health Organization; 2012. Available from: http://www.who.int/choice/en/ [cited 2012 Nov 12].

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses;PharmacoEconomics;2024-08-07

2. Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis;BMC Infectious Diseases;2023-05-05

3. Treatment Outcomes and Risk Factors of Multidrug-Resistant Tuberculosis Patients in Xi’an China, a Retrospective Cohort Study;Infection and Drug Resistance;2022-08

4. The Potential Role of Vitamin D in the Development of Tuberculosis in Chinese Han Population: One Case-Control Study;Frontiers in Medicine;2022-07-25

5. Inclusion of Additional Unintended Consequences in Economic Evaluation: A Systematic Review of Immunization and Tuberculosis Cost-Effectiveness Analyses;PharmacoEconomics - Open;2021-05-04